| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 3.526 | 0 | 0 | 0 | 31.322 | 83.246 | 100.247 | 95.451 |
| Total Income - EUR | - | - | 3.526 | 0 | 0 | 0 | 31.323 | 83.256 | 101.609 | 96.385 |
| Total Expenses - EUR | - | - | 284 | 38 | 0 | 0 | 8.623 | 20.413 | 42.416 | 47.149 |
| Gross Profit/Loss - EUR | - | - | 3.242 | -38 | 0 | 0 | 22.700 | 62.842 | 59.193 | 49.236 |
| Net Profit/Loss - EUR | - | - | 3.140 | -38 | 0 | 0 | 22.570 | 62.026 | 58.197 | 46.403 |
| Employees | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Alergocenter Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 27 | 0 | 0 | 0 | 746 | 646 | 1.221 | 761 |
| Current Assets | - | - | 3.259 | 14 | 14 | 13 | 23.350 | 63.331 | 58.520 | 51.177 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 352 | 0 | 0 | 0 | 1.111 | 47.986 | 50.162 | 39.062 |
| Cash | - | - | 2.906 | 14 | 14 | 13 | 18.196 | 11.290 | 770 | 186 |
| Shareholders Funds | - | - | 3.184 | 14 | 14 | 13 | 22.583 | 62.075 | 58.245 | 46.451 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 102 | 0 | 0 | 0 | 1.601 | 1.953 | 1.508 | 5.487 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alergocenter Srl